Yes, do explain how you can be happy with:
-450k base wage plus 150k bonus for a CEO of a speculative stock years from profitability. + options/performance shares.
-Slow progress.
-Ambiguous and dishonest information release. Just 1 example is an interview where "plasma levels are adequate", whilst the company doubles back to a phase 1 trial to desperately increase infusion rates to boost plasma concentrations, all while not releasing results to share holders.
Ann: Murdoch Children's R327 Efficacy UTI in-vivo, page-20
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $112.1M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 56.0¢ | 54.0¢ | $48.29K | 87.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4874 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.48pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
55.5¢ |
Change
0.000 ( 1.83 %) |
||||
| Open | High | Low | Volume | ||
| 56.0¢ | 56.0¢ | 54.0¢ | 13528 | ||
| Last updated 15.44pm 17/06/2024 ? | |||||
| RCE (ASX) Chart |
